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Pro-oxidant/antioxidant balance controls pancreatic
β-cell differentiation through the ERK1/2 pathway
E Hoarau1,2, V Chandra1,2, P Rustin3, R Scharfmann1,2 and B Duvillie*,1,2
During embryogenesis, the intrauterine milieu affects cell proliferation, differentiation, and function by modifying gene expression
in susceptible cells, such as the pancreatic β-cells. In this limited energy environment, mitochondrial dysfunction can lead to
overproduction of reactive oxygen species (ROS) and to a decline in β-cell function. In opposition to this toxicity, ROS are also
required for insulin secretion. Here we investigated the role of ROS in β-cell development. Surprisingly, decreasing ROS production
in vivo reduced β-cell differentiation. Moreover, in cultures of pancreatic explants, progenitors were highly sensitive to ROS
stimulation and responded by generating β-cells. ROS enhanced β-cell differentiation through modulation of ERK1/2 signaling.
Gene transfer and pharmacological manipulations, which diminish cellular ROS levels, also interfered with normal β-cell
differentiation. This study highlights the role of the redox balance on β-cell development and provides information that will be
useful for improving β-cell production from embryonic stem cells, a step in cell therapy for diabetes.
Cell Death and Disease (2014) 5, e1487; doi:10.1038/cddis.2014.441; published online 23 October 2014
Reactive oxygen species (ROS) exist in all aerobic cells, and
their level is controlled by a balance between pro-oxidants and
antioxidants. ROS include the superoxide radical, hydrogen
peroxide (H2O2), singlet oxygen, and the hydroxyl radical. An
excess of ROS leads to oxidative stress, one of the most
important regulatory mechanisms for cancer cells, and cancer
stem cells.1 During the past decade, the cytotoxic effects of
ROS have been implicated in various human diseases
including cancer and Parkinson’s disease.2 However, low
physiological levels of ROS have also been reported recently
to operate as signaling molecules.3 Indeed, depending on the
context, ROS can modulate cell proliferation,4 survival,5 and
differentiation.6
The endocrine pancreas is exceptionally sensitive to
variations in intracellular levels of ROS. Indeed, ROS-
inactivating enzymes are expressed at very low levels in
pancreatic β-cells, rendering them highly sensitive to oxidative
stress.7,8 Hyperglycemia is a cause of oxidative stress-related
damage in a number of cell types, including neurons, retinal
cells, vascular endothelium,9 and pancreatic β-cells. Persis-
tent hyperglycemia in diabetes increases ROS production by
glucose autoxidation,10 activation of protein kinase C (PKC),
and increased flux through the hexosamine pathway.9
In human type II diabetes, the link between oxidative stress
and β-cell dysfunction is well established.11,12 However,
despite these toxic effects, recent findings have shed light
on the necessity of ROS for β-cell function.13
Redox status has been suggested to modulate stemness
and lineage commitment in several precursor cell types.14
In this study, we researched the effects of ROS on pancreatic
progenitor cells. Pancreas development is governed by a
hierarchy of transcription factors.15 In the mouse, embryonic
pancreatic progenitors arise at ∼E9 from the primitive
intestine, expressing the homeodomain transcription factor
PDX1 (pancreatic and duodenal homeobox 1).16 PDX1
is necessary for the morphogenesis and differentiation
of the pancreatic buds in both rodents and humans.17,18
Upon FGF10 signaling, the pancreatic epithelium grows.19
Endocrine progenitors that transiently express the transcrip-
tion factor neurogenin 3 (NGN3) will give rise to all of the
pancreatic endocrine cell types.20
Here, we investigated the role of ROS in endocrine
pancreas development. We first showed that treatment of
pregnant rats with N-acetyl-cysteine (NAC) decreases β-cell
differentiation in their progeny. We then investigated by which
mechanism ROS control β-cell differentiation. Using culture
models, we showed that H2O2 enhances the generation of
β-cells in the rat embryonic pancreas. Using both chemical
and genetic approaches, we next demonstrated that over-
expression of catalase decreases β-cell differentiation. This
effect of catalase was mimicked by the antioxidant NAC or the
decoupling agent carbonyl cyanide m-chlorophenyl hydra-
zone (CCCP) that both decrease ROS production. We finally
found that the ERK1/2 pathway was activated by H2O2 and,
interestingly, the effect of H2O2 on β-cell differentiation was
blunted by an inhibitor of the ERK1/2 pathway. Altogether,
these data demonstrate that pancreatic endocrine cell
development is tightly dependent of ROS.
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Results
ROS are required for β-cell development in vivo. Several
stem cell types are sensitive to ROS signals.21,22 Here, we
investigated whether endocrine cell development is modu-
lated by ROS in the embryonic pancreas in vivo. First, we
quantified the expression of antioxidant enzyme genes in the
embryonic and adult pancreases and livers (Supplementary
Figure S1). Catalase and glutathione peroxidase (Gpx) are
responsible for the degradation of H2O2. At the adult stage,
their mRNA levels were reduced in pancreases compared
with livers (Supplementary Figure S1) and were even lower
in embryonic (E13.5) pancreases. These data suggest that
developing embryonic pancreas is highly susceptible to
oxidative stress because of low expression of these ROS-
scavenging enzymes. Moreover, if not eliminated by Catalase
or Gpx, H2O2 can activate signaling pathways,
23 potentially
involved in cell division and differentiation within a narrow
window of development.24
Therefore, we tested whether modulating the level of ROS
would affect pancreatic endocrine development. We treated
pregnant rats at 13.5 days post coitum with NAC, a precursor
of the biologic antioxidant gluthatione, and examined
pancreatic development in their progeny at E20.5. The
morphology of the treated pancreas was normal (Figure 1
and Supplementary Figure S2). The presence of acinar cells,
and also α-, β-, and δ-cells, was detected using anti-amylase,
anti-glucagon, anti-insulin, and anti-somatostatin antibodies,
respectively (Supplementary Figure S2 and Figure 1b). The
endocrine progenitors were next detected using anti-NGN3
antibodies (Figure 1a). We observed a decreased number of
NGN3-positive cells (1.6-fold) in the pancreases from fetuses
treated with NAC compared with controls (Figure 1a),
suggesting a reduction of endocrine differentiation. To confirm
this hypothesis, we quantified the α-cell and β-cell masses.We
found a 3.3-fold decrease of the α-cell mass and a 2.5-fold
reduction of the β-cell mass in the pancreases treated with
NAC (Supplementary Figure S2 and Figure 1b). These results
thus implicate ROS in β-cell differentiation.
ROS enhance β-cell differentiation in embryonic pan-
creases. To investigate how ROS regulate pancreatic β-cell
development, we cultured E13.5 rat pancreases with various
concentrations of ROS. Instead of manipulating superoxide
levels, which is a difficult task because of its short half-life,25
we used H2O2. Indeed, H2O2 is diffusible and penetrates
efficiently into the cells.23 Using polarography we first
determined H2O2 stability in our culture conditions by
measuring its decay over time26 (Supplementary Figure S3).
We found that 50% of the initial quantity of H2O2
remains present after 4 h in the culture medium. Next,
pancreatic explants were treated with increasing concentra-
tions (0–100 μM) of H2O2. We first attempted to apply H2O2
every day during the culture period, but such treatment
became toxic after 3 days (data not shown). Therefore, in the
following experiments, H2O2 was added only at the beginning
of the culture. When H2O2 treatment was applied to cultured
pancreases, expression of the oxidative stress response
genes, nuclear-factor E2 related Factor 2 (Nrf2) and heme
oxygenase 1 (HO-1) was upregulated (1.6-fold and 2-fold
respectively, Supplementary Figure S4). Interestingly, after
7 days in culture, the development of β-cells was increased
with 50 and 75 μM H2O2, the surface occupied by insulin-
positive cells being 2.6- and 2-fold larger than controls
(Figures 2a and b). At two other concentrations, 25 and
100 μM, we also observed a slight increase of β-cell
development. To confirm this effect of H2O2, we also
quantified insulin content in pancreases that develop with
H2O2 treatment. We found a 1.6-fold increase in pancreases
cultured 7 days with H2O2 compared with controls
(Supplementary Figure S5). The transcription factor PDX1,
which is expressed in mature differentiated β-cells,27 was
present in all the insulin-positive cells (Supplementary Figure
S6), confirming that H2O2 enhances β-cell development.
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Figure 1 Antioxidant NAC decreases β-cell differentiation in vivo. Pregnant rats were treated with 10 mM NAC from 13.5 days post coitum. Embryonic pancreases were
analyzed at E20.5 (a) NGN3 expression (in brown) was detected by immunohistochemistry, and the number of NGN3-positive cells was quantified. (b) Islets were detected in
treated and control embryonic pancreases using anti-insulin (red) and anti-glucagon antibodies (green). Nuclei were stained with Hoechst 33342 (blue). The β-cell mass was then
calculated. Each point represents the mean±S.E.M. of three individual data pools. *Po0.05. Scale bar: 50 μm
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Wenext sought to determine the mechanism bywhich H2O2
increases β-cell development. We tested whether H2O2
increases the survival or the proliferation of progenitor cells,
or amplifies the differentiation of progenitor cells into β-cells.
After 1 day of culture in the presence or in the absence of
H2O2, the rate of apoptosis measured using a TUNEL reaction
did not differ between the H2O2-treated pancreases and
controls (Figure 3a). The β-cell proliferation measured follow-
ing BrdU incorporation was similar in pancreases cultured with
or without H2O2 (Figure 3b). Finally, we investigated the effect
of H2O2 on β-cell differentiation. The number of NGN3-positive
endocrine progenitor cells was increased by nearly twofold in
pancreases cultured with H2O2 (Figure 3c), followed by an
increased number of β-cells (Figure 3d). Thus, these results
show that H2O2 controls β-cell differentiation. To confirm this
result, we cultured pancreases with glucose oxidase (GOx),
an enzyme that oxidizes glucose into H2O2 and D-glucono-
lactone. In the presence of GOx, H2O2 is continuously
generated in the medium. We found that the number of
NGN3-positive cells was increased 2.2-fold in the presence of
GOx compared with controls (Supplementary Figure S7).
These data thus demonstrate that ROS have a positive and
nontoxic effect on β-cell development.
Increasing catalase levels alters Ngn3 expression. In
order to control H2O2 production, we manipulated catalase
expression that catalyzes the degradation of H2O2 into water
and oxygen. Catalase level was increased by using both
pharmacological and genetic methods. E13.5 pancreases
were first cultured for 1 day with exogenous catalase.
We observed a 3.3-fold decrease in the number of
NGN3-expressing cells compared with controls (Figure 4a).
Consistent with this result, we observed a 1.75-fold reduction
of the insulin-staining surface in pancreases treated with
catalase (Figure 4b).
We next increased endogenous catalase expression using
adenoviral transduction. E13.5 pancreatic epithelia were
infected with adenoviruses coding either for catalase
(Ad-Cat) or green fluorescent protein (Ad-GFP, control).
Pancreases infected with Ad-GFP were negative for catalase
protein expression. Following Ad-Cat transduction, catalase
expression was found in many pancreatic epithelial cells
(Supplementary Figure S8). However, some cells at the center
of the rudiments were not reached by the virus. Therefore, a
milder effect of Ad-Cat on β-cell differentiation was expected
as compared with the exogenous catalase treatment. Infection
with Ad-Cat did not modify epithelial progenitor cell apoptosis
as measured by TUNEL assay, nor progenitor cell proliferation
as measured by quantification of BrdU incorporation (Figures
5a and b). On the other hand, the number of NGN3-positive
endocrine progenitor cells was decreased by 1.6-fold in
pancreases infected by Ad-Cat compared with pancreases
infected by Ad-GFP (Figure 5c). Finally, β-cell development
was decreased in pancreases infected with Ad-Cat versus
controls (Figure 5d). Altogether, these data demonstrate that
catalase levels regulate β-cell development.
Effects of ROS modulators on endocrine cell development.
To further determine the effects of ROS modulators on
endocrine cell differentiation, we cultured embryonic
pancreases in the presence of the antioxidant NAC.
This treatment decreased nearly twofold the number of
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Figure 2 Effect of H2O2 on β-cell development. (a) E13.5 rat pancreases were cultured for 7 days with H2O2 (0–100 μM). At day 7, anti-insulin antibody (red) was used to
detect β-cell development. Nuclei were stained with Hoechst 33342 (blue). Scale bar: 50 μm. (b) The absolute surface area occupied by insulin-positive cells was quantified. Each
point represents the mean±S.E.M. of three individual data pools. *Po0.05; **Po0.01
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NGN3-positive endocrine progenitor cells, followed by a
decrease of β-cell development (Figures 6a and b).
Mitochondria are the major site of ROS production.28 To
determine the implication of mitochondria in β-cell develop-
ment, we used the mitochondrial decoupling agent CCCP.
This compound is known to decrease ROS levels. We found
that CCCP reduced the number of NGN3-positive cells at day
1 and the insulin-staining surface at day 7 (Figures 6a and b).
We thus conclude that endogenous ROS are mandatory for
β-cell differentiation. Moreover, the effects obtained with
CCCP suggest that in this process, ROS have probably
a mitochondrial origin.
Regulation of β-cell development by ROS levels depends
on ERK1/2 signaling. We next characterized the molecular
mechanisms by which H2O2 increased β-cell development.
We examined the mitogen-activated protein kinase (MAPK)
ERK1/2 pathway that was recently shown to be sensitive to
ROS production in several cell types.29 Pancreases were
cultured with or without H2O2 (50 μM) for 5 or 15min. In
parallel experiments, pancreases were treated with 20mM
glucose, a well-known inducer of ERK1/2 phosphorylation in
β-cells and fetal islets.30,31 Western blot analysis showed
that H2O2, similar to high glucose, induced the ERK1/2
pathway (Figure 7a). Such an induction of the ERK1/2
pathway by H2O2 was also observed by immunohisto-
chemistry (Supplementary Figure S9).
To characterize the link between the ROS-activated ERK1/2
pathway and endocrine development, we used U0126, an
inhibitor of ERK1/2 phosphorylation. When explants cultured
with high glucose levels were treated with U0126, activation
of ERK1/2 was abolished (Figure 7a and Supplementary
Figure S9), validating the efficiency of the ERK1/2 inhibitor.
We next compared the phosphorylation of ERK1/2 by H2O2 in
the presence or absence of U0126. As expected, activation of
the ERK1/2 pathway by H2O2 was blunted in the presence of
U0126 (Figure 7a and Supplementary Figure S9). We next
researched whether ERK1/2 activation by H2O2 is necessary
for the induction of β-cell differentiation. For this, pancreases
were treated with H2O2 in the presence or absence of U0126
and NGN3 expression was analyzed. Treatment of pan-
creases with H2O2 considerably increased the number of
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Figure 3 H2O2 induces β-cell differentiation. (a) Apoptotic cells (in green) were detected using a TUNEL reaction assay in pancreases cultured for 1 day with or without 50 μM
H2O2. The epithelial cells were detected using an anti-E-cadherin antibody (in red). Note the absence of apoptotic cells within the epithelium. Next, apoptosis percentage was
calculated. Scale bar: 50 μm. (b) BrdU was added 1 h before the end of culture. Proliferation of early PDX1+ progenitors was observed in pancreases cultured for 1 day with or
without 50 μM H2O2 (PDX1 in green and BrdU in red). Proliferation percentage was also quantified. Scale bar: 50 μm. (c) On day 1, NGN3 expression (in brown) was detected by
immunohistochemistry. For each pancreas, the number of NGN3+ cells was quantified. Scale bar: 25 μm (d) On day 7, immunohistochemistry was performed to detect insulin (in
red). Nuclei were stained with Hoechst 33342 (blue). The insulin-stained surface was measured under both conditions. Each point represents the mean±S.E.M. of three
individual data pools. Scale bar: 50 μm. *Po0.05; **Po0.01
ROS and β-cell differentiation
E Hoarau et al
4
Cell Death and Disease
NGN3-expressing cells (Figure 7b). Interestingly, the repres-
sion of ERK1/2 by U0126 abolished the inductive effect of
H2O2 on NGN3 expression (Figure 7b). Altogether, these
results demonstrate that the effects of H2O2 on β-cell
differentiation are mediated by the ERK1/2 pathway.
Discussion
ROS regulate pancreatic progenitor cell differentiation.
Here we have demonstrated that ROS have a significant
impact on pancreatic progenitor cell differentiation. This result
was unexpected as ROS have been implicated in β-cell
toxicity in other models. For example, uteroplacental insuffi-
ciency in rats leads to intrauterine growth retardation (IUGR)
and disrupts the function of the electron transport chain in the
fetal β-cell. This process induces increased production of
ROS that in turn damages mitochondrial DNA and causes
further production of ROS.32 These events are involved in a
progressive loss of β-cell function and type II diabetes in the
adult. This model of IUGR is thought to mimic type II diabetes
in humans, with progressive defects in insulin secretion and
insulin action before hyperglycemia. A difference between the
IUGR model and the present study is that the increase of
ROS occurred in differentiated β-cells in the IUGR model
downstream to Ngn3, whereas we manipulated ROS signals
upstream of Ngn3.
Contrary to the IUGR animals that display toxic oxidative
stress in β-cells, ROS were found to increase insulin secretion
in other models.13,33 For example, JunD− /− mice, which
have a shortened lifespan, displayed hyperinsulinemia asso-
ciated with increased pancreatic islet vascularization and
chronic oxidative stress. Interestingly, long-term treatment of
these mice with NAC from embryogenesis to adulthood
restored blood glucose and plasma insulin, suggesting that
antioxidant prevent insulin secretion.33 However, the treat-
ment of wild-type (WT) mice with NAC did not alter glycemia or
insulinemia.33 In this study of Laurent et al.,33 it would have
been interesting to determine whether NGN3 expression
varied in correlation with NAC supply. Moreover, the quanti-
fication of the β-cell mass at adulthoodwould allow to establish
a link between ROS levels and the quantity of β-cells. Finally,
in vitro experiments showed that incubation of rat islets with
another antioxidant, trolox, blunted glucose-stimulated insulin
secretion.13 Together, these data indicate that ROS, in
addition to their role on β-cell development, have a crucial
role on insulin secretion.
ROS and MAPK signaling. In this study, H2O2 increased
β-cell differentiation. As the half-life of H2O2 was only hours in
the culture medium (Supplementary Figure S3), we expected
to find a short-term activation of the signalization responsible
for the upregulation of Ngn3 expression and observed that
ERK1/2 activation occurred only 5min after the addition of
H2O2. Moreover, using an ERK1/2 inhibitor, we showed that
an intact ERK1/2 pathway is necessary for the effects of
H2O2 on endocrine differentiation. Interestingly, a link
between ERK1/2 and β-cell development has been sug-
gested previously. For example, an activation of the MAPK/
ERK1/2 pathway by fibroblast growth factor-10 controls β-cell
development.19,34 Moreover, in humans, β1-integrin/focal
adhesion kinase activation of ERK1/2 is essential for human
fetal islet maturation and survival.35 Such data reinforce our
conclusion on the role of ERK1/2 in β-cell development, and
indicate that the ERK1/2 pathway is controlled by different
signals in the embryonic pancreas. Several studies have also
shed light on the implication of ERK1/2 in the biology of
differentiated β-cells. In the MIN6 β-cell line, ERK1/2 controls
phosphorylation and protein level of cAMP-responsive ele-
ment-binding protein (CREB), playing a key role in β-cell
survival.36 Moreover, ROS are also required for insulin
secretion in β-cells.13 Further studies will allow to establish
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Figure 4 Exogenous catalase reduces β-cell differentiation. E13.5 pancreases
were cultured for 1 to 7 days with or without catalase at 300 U/ml. (a) After 1 day of
culture, NGN3 expression was detected by immunohistochemistry (in brown). The
absolute number of NGN3+ cells was quantified. (b) After 7 days, β-cell area (in red)
was detected by immunohistochemistry and quantified. Nuclei were stained with
Hoechst 33342 (blue). Each point represents the mean± S.E.M. of three individual
data pools. Scale bar: 50 μm. *Po0.05; **Po0.01
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the exact link between ROS and ERK1/2 in β-cell develop-
ment and function.
The effects of ROS on stem cell or progenitor cell
differentiation are context dependent. Recent data high-
lighted the role of ROS in the differentiation of embryonic
stem cells, induced pluripotent stem cells (iPS), and some
adult stem cells, including hematopoietic stem cells or neural
stem cells.22,37 In these processes, both pluripotent and
multipotent stem cells use enzymatic and nonenzymatic
mechanisms for detoxification of ROS and for correction of
oxidative damage to the genome or the proteome. Interest-
ingly, a correlation exists between the antioxidant defense
level and stem cell proliferation, differentiation, and death.14
Despite the broad influence of ROS-mediated signaling on
cell differentiation, in many cases, cellular response to ROS
depends on different cellular parameters, such as cell-type
phenotype, cell differentiation state, and the presence of
cell-specific transcription factors.22 Indeed, the variety of
signals induced by H2O2 is wide. They include SIRT1
deacetylase, calcium influx, Nrf2, and PI3Kinase/Akt.38–40
Genotoxic stress caused by ROS may also induce the
differentiation of cell types such as melanocytes.41 Thus, we
cannot formally exclude that one of these processes is
implicated in β-cell differentiation, in complement to ERK1/2
pathway. Further investigation will be performed to elucidate
the role of other candidate pathways that may also exert an
effect on β-cell differentiation in combination with ERK1/2.
In conclusion, we have identified a redox-mediated regula-
tory mechanism of differentiation that is required for β-cell
development. This concept is counterintuitive. However, the
possibility of a physiological role of ROS is in accordance with
the findings showing that ROS are necessary for the function
of β-cells.13 Moreover, it was recently postulated that type II
diabetes is caused rather by a lack of biological oxidants than
an excess of ROS.42 In this hypothesis, a failure of ROS could
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Figure 5 Catalase overexpression decreases NGN3 expression in the pancreatic epithelium. E13.5 rat pancreatic epithelia were infected by adenovirus coding either for GFP
(controls) or for catalase and cultured for 1, 3, or 7 days. (a) Apoptotic cells (in green) were detected using a TUNEL reaction assay at culture day 1. The epithelial cells were
detected using an anti-E-cadherin antibody (in red). Next, apoptosis percentage of epithelial cells was calculated. Scale bar: 50 μm. (b) Proliferation of early PDX1+ progenitors
was detected by immunohistochemistry (PDX1 in green and BrdU in red) at culture day 1. Proliferation percentage was also quantified. Scale bar: 50 μm. (c) On day 3, NGN3
expression (in brown) was detected by immunohistochemistry and the number of NGN3+ cells per epithelium was quantified. Scale bar: 25 μm. (d) After 7 days, β-cell area (in
red) was detected by immunohistochemistry and quantified. Nuclei were stained with Hoechst 33342 (blue). Each point represents the mean± S.E.M. of three individual data
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have wide effects, and be a cause of diabetes, cardiovascular
disease, and some cancers. Our new data on the role of ROS
during embryogenesis converge with this theory. In addition,
our new findings also open perspectives for the generation of
pancreatic β-cells from embryonic stem cells in order to
develop a cell-based therapy of diabetes. Dissecting the
defined roles of ROS in pancreatic progenitors will also greatly
enhance their basic and translational applications.
Materials and Methods
Animals. Pregnant Wistar rats were purchased from the Janvier Breeding center
(CERJ Janvier, Le Genest-Saint-Isle, France). The animals had free access to food
pellets and water. Embryonic day 0.5 (E0.5) was considered the first day post
coitum. Pregnant rats were killed by CO2 asphyxiation according to the guidelines of
the French Animal Care Committee.
NAC (Sigma, Saint-Quentin Fallavier, France) treatment was initiated during
embryonic life at E13.5 and given into drinking water to pregnant rats.
Pancreatic dissection and culture. At E13.5, the dorsal pancreatic bud
was dissected, as described previously.34 For the depletion of the mesenchyme, the
digestive tract was incubated with 0.5 mg/ml collagenase A (Roche, Meylan,
France) at 37 °C for 30 min, then washed several times with Hank’s balanced
solution (Invitrogen, Cergy-Pontoise, France) at 4 °C, and the epithelium was
mechanically separated from the mesenchyme using needles on 0.25% agar, 25%
Hank’s balanced solution, and 75% RPMI gel (Life Technologies, Saint-Aubin,
France) in a Petri dish. Pancreatic rudiments (epithelium with mesenchyme) or
epithelia were then cultured at the air–medium interface on Millicell culture plate
inserts (Millipore, Molsheim, France) in Petri dishes containing RPMI-1640
(Invitrogen) supplemented with penicillin (100 U/ml), streptomycin (100 g/ml),
HEPES (10 mM), L-glutamine (2 mM), non-essential amino acids (1 × ; Invitrogen),
and 10% heat-inactivated calf serum (Hyclone, South Logan, UT, USA) for 1 to
7 days. H2O2 (Sigma) was used at 25, 50, 75, and 100 μM. Glucose (Sigma) was
used at 20 mM, glucose oxidase (Sigma) at 0.3 μ/ml, and the inhibitor of the ERK
pathway (U0126, Cell Signaling Technologies Ozyme, Saint-Quentin, France) at
10 mM. Cultures were maintained at 37 °C in humidified 95% air and 5% CO2.
For proliferation measurement, BrdU (Sigma) was added during the last hour of
culture (10 μM).
For β-cell mass, pancreases were weighted. This weight was then multiplied by the
corresponding β-cell fraction for each pancreas.
Infection. Ad-CMV-GFP (ref 1060, Vector Biolabs, Philadelphia, PA, USA) and
Ad-Catalase (ref 1475, Vector Biolabs) adenoviruses were used to infect the
embryonic Wistar rat epithelia. Tissues were incubated with viral particles at the
multiplicity of infection of 1000 for 4 h at 37 °C in RPMI-1640 as described in Heinis
et al.43 After infection, tissues were washed twice in HBSS and cultured at the
air–medium interface.
Immunohistochemistry. Tissues were fixed in 10% formalin and processed
for immunohistochemistry, as described previously.34 The following antibodies were
used: mouse anti-insulin (1 : 2000; Sigma-Aldrich, Saint-Quentin Fallavier, France),
rabbit anti-glucagon (1 : 1000; Euromedex, Souffelweyerrsheim, France), rabbit anti-
somatostatin (1 : 500; Dako, Glostrup, Denmark), rabbit anti-PDX1 (1 : 1000), rabbit
anti-amylase (Sigma-Aldrich, 1 : 300), mouse anti-E-cadherin (1 : 100, BD
Biosciences, Le Pont de Claix, France), mouse anti-BrdU (1 : 2, Amersham,
Velizy-Villacoublay, France), rabbit anti-NGN3 (1 : 1000),44 rabbit anti-catalase
(1 : 1000; Rockland Immunochemicals, Gilbertsville, PA, USA), rabbit anti-Phospho-
p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (1 : 200; Cell Signaling, Leiden,
Netherlands), and rabbit anti-p44/42 MAPK (Erk1/2) (1 : 200; Cell Signaling).
The fluorescent secondary antibodies were fluorescein isothiocyanate anti-rabbit
and Texas Red anti-mouse antibodies (1 : 200, Jackson Immunoresearch, Suffolk,
UK), and Alexa-fluor anti-rabbit antibody (1 : 400, Biogenex, Fremont, CA, USA).
For NGN3, revelation was performed using the vectastain ABC kit (Vector LAB,
Peterborough, UK). Fluorescent image acquisition was performed using an inverted
fluorescence microscope Zeiss AxioObserver Z1 coupled with MRm Axiocam Zeiss
(Zeiss, Marly le Roi, France).
Insulin content. Pancreatic explants were cultured for 1 week. On day 7,
pancreases were washed twice in Glucose-free HEPES-buffered Krebs-Ringer
Buffer (116 mM NaCl, 5.06 mM KCl, 1.007 mM CaCl2, 1.01 mM MgCl2, 1.19 mM
KH2PO4, 23.96 mM NaHCO3, 10 mM HEPES, pH 7.4, and 0.2% BSA). Pancreases
were then collected in a tube and TetG was added. Tissues were then sonicated,
centrifuged, and the supernatants were collected. Supernatants containing insulin
were then tested using the Ultrasensitive Rat Insulin ELISA kit (Mercodia, Uppsala,
Sweden) according to the manufacturer’s instructions.
Transferase-mediated dUTP nick-end labeling experiments. The
TUNEL procedure was performed using an in situ cell death detection kit (Roche)
according to the manufacturer’s instructions. Subsequently, E-cadherin (1 : 100,
BD Biosciences) immunostaining was used to visualize the epithelium.
Real-time PCR. Total RNA was purified using the Rneasy microkit (Qiagen,
Courtaboeuf, France). The cDNA was generated using Superscript reagents
(Invitrogen), and the real-time PCR was performed on a 7300 real-time PCR system
(Applied Biosystem, Life Technologies) with a SYBR Green PCR master mix.
Cyclophilin A was used as housekeeping gene. The oligonucleotide sequences for
RT-PCR are available on request.
H2O2 stability measurement. Residual H2O2 was quantified by polaro-
graphic determination of the oxygen released upon addition of 10 μg of purified beef
liver catalase resuspended in 50 mM phosphate buffer pH 7.0 (Sigma) to 250 μl
culture medium samples placed in an oxygen polarograph (Hansatech,
Norfolk, UK).
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Figure 6 N-acetyl-cysteine and the mitochondrial agent CCCP alter β-cell
differentiation. E13.5 rat pancreases were cultured for 1 and 7 days with or without
NAC at 10 μM or CCCP at 1 μM. (a) After 1 day, NGN3 expression (in brown) was
detected by immunohistochemistry. The number of NGN3+ cells per epithelium was
quantified. Scale bar: 25 μm. (b) On day 7, β-cell area (in red) was detected by
immunohistochemistry and quantified. Nuclei were stained with Hoechst 33342
(blue). Each point represents the mean± S.E.M. of three individual data pools. Scale
bar: 50 μm. *Po0.05; **Po0.01
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Figure 7 Activation of ERK1/2 phosphorylation by H2O2 is required for the proper development of β-cells. (a) E13.5 rat pancreases were cultured for 0, 5, or 15 min with or
without 50 μM H2O2 in association or not with U0126. Glucose 20 mM was used as a positive regulator of ERK1/2. Protein extracts from cultured pancreases were analyzed by
western blot to quantify P-ERK1/2. Total ERK is used as loading control. Relative ERK Phosphorylation was also quantified for each condition. (b) E13.5 rat pancreases were
cultured with or without H2O2 at 50 μM, in association or not with the ERK1/2 inhibitor U0126. For each condition, NGN3 expression (in brown) was detected by
immunohistochemistry and the number of NGN3+ cells was quantified. Each point represents the mean± S.E.M. of three individual data pools. Scale bar: 25 μm. *Po0.05;
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Western blot analysis. For western blotting analysis, cells were lysed in
Laemmli buffer. Proteins (20 μg) were resolved by SDS-PAGE and electrophor-
etically transferred onto PVDF membrane (Bio-Rad, Hercules, CA, USA). After
blocking with milk, membranes were probed with rat anti-p44/42 MAPK (Erk1/2)
(Cell Signaling) and mouse anti-Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204,
Cell Signaling). Immunoreactive bands were visualized with the SuperSignal System
(Pierce, Fisher Scientific, Illkirch, France).
Quantification. To quantify the absolute number of insulin-expressing cells, all
sections of each pancreatic rudiment were digitized. On every image, the surface
area of insulin staining was quantified using ImageJ (NIH, Washington, WA, USA)
as described previously.43
To quantify the number of NGN3-positive cells, cells immunopositive for NGN3 were
counted on all sections. Statistical significance was determined using Student’s t-test.
To measure the proliferation of early progenitors expressing E-cadherin, we counted
the frequency of BrdU+ nuclei among 1000 PDX1+ cells. Three rudiments per condition
were analyzed. Statistical significance was determined using Student’s t-test.
To measure cell survival, we counted the frequency of TUNEL+ cells among
E-cadherin+ cells. Statistical significance was determined using Student’s t-test.
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